| The rising price of naloxone—risks to efforts to stem overdose deaths R Gupta, ND Shah, JS Ross New England journal of medicine 375 (23), 2213-2215, 2016 | 158 | 2016 |
| Generic drugs in the United States: Policies to address Pricing and Competition R Gupta, ND Shah, JS Ross Clinical Pharmacology & Therapeutics 105 (2), 329-337, 2019 | 51 | 2019 |
| Generic drug approvals since the 1984 Hatch-Waxman Act R Gupta, AS Kesselheim, N Downing, J Greene, JS Ross JAMA internal medicine 176 (9), 1391-1393, 2016 | 51 | 2016 |
| The FDA Unapproved Drugs Initiative: an observational study of the consequences for drug prices and shortages in the United States R Gupta, SS Dhruva, ER Fox, JS Ross Journal of managed care & specialty pharmacy 23 (10), 1066-1076, 2017 | 39 | 2017 |
| Affordability and availability of off-patent drugs in the United States—the case for importing from abroad: observational study R Gupta, TJ Bollyky, M Cohen, JS Ross, AS Kesselheim bmj 360, 2018 | 26 | 2018 |
| High Costs of FDA Approval for Formerly Unapproved Marketed Drugs A Hakim, R Gupta, JS Ross Jama 318 (22), 2181-2182, 2017 | 17 | 2017 |
| Naloxone prescriptions following emergency department encounters for opioid use disorder, overdose, or withdrawal AS Kilaru, M Liu, R Gupta, J Perrone, MK Delgado, ZF Meisel, ... The American Journal of Emergency Medicine, 2021 | 15 | 2021 |
| Spending by the Centers for Medicare & Medicaid Services Before and After Confirmation of Benefit for Drugs Granted US Food and Drug Administration Accelerated Approval, 2012 … JJ Skydel, AC Egilman, JD Wallach, R Ramachandran, R Gupta, JS Ross JAMA Health Forum 3 (5), e221158, 2022 | 9 | 2022 |
| Consumer Views on Privacy Protections and Sharing of Personal Digital Health Information R Gupta, R Iyengar, M Sharma, CC Cannuscio, RM Merchant, DA Asch, ... JAMA Network Open 6 (3), e231305-e231305, 2023 | 8 | 2023 |
| Policy Options For Increasing Generic Drug Competition Through Importation M Cohen, R Gupta, TJ Bollyky, JS Ross, AS Kesselheim Health Affairs Blog, 2019 | 6 | 2019 |
| The impact of off-patent drug acquisitions on prices R Gupta, A Henkel, HP Forman, JS Ross Journal of General Internal Medicine 33, 1007-1009, 2018 | 6 | 2018 |
| Medicare Formulary Coverage of Brand-Name Drugs and Therapeutically Interchangeable Generics A Vijay, R Gupta, P Liu, SS Dhruva, ND Shah, JS Ross Journal of General Internal Medicine, 1-3, 2019 | 5 | 2019 |
| Approvals and Timing of New Formulations of Novel Drugs Approved by the US Food and Drug Administration Between 1995 and 2010 and Followed Through 2021 R Gupta, CJ Morten, AY Zhu, R Ramachandran, ND Shah, JS Ross JAMA Health Forum 3 (5), 2022 | 4 | 2022 |
| Prevalence of Third-party Tracking on Medical Journal Websites R Gupta, AB Friedman, MS McCoy JAMA Health Forum 3 (3), 2022 | 4 | 2022 |
| Prioritization of Generic Drug Review—Reply R Gupta, AS Kesselheim, JS Ross JAMA internal medicine 177 (1), 141-142, 2017 | 4 | 2017 |
| Digital privacy and data protection: From ethical principles to action R Gupta The American Journal of Bioethics 23 (11), 24-26, 2023 | 3 | 2023 |
| Characteristics of Recent Generic Drug Approvals by the US Food and Drug Administration K Jiao, R Gupta, E Fox, A Kesselheim, JS Ross JAMA network open 2 (10), e1913029-e1913029, 2019 | 3 | 2019 |
| An Unnecessary Gift for COVID-19 Vaccines and Therapeutics: The Medical Countermeasure Priority Review Voucher R Ramachandran, R Gupta, J Luo American Journal of Public Health 111 (11), 1923-1926, 2021 | 2 | 2021 |
| Assessing community health research capacity across stakeholders: adapting a tool D Humphries, R Gupta, T Dukpa, D Wangmo Health Promotion International 36 (4), 1198-1208, 2021 | 2 | 2021 |
| Medicaid Expansion And Outpatient Cardiovascular Care Use Among Low-Income Nonelderly Adults, 2012–15: Study examines Medicaid expansion and outpatient cardiovascular care use … SAM Khatana, L Yang, LA Eberly, AS Nathan, R Gupta, SA Lorch, ... Health Affairs 42 (11), 1586-1594, 2023 | 1 | 2023 |
